chr12-9997193-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_016509.4(CLEC1B):āc.250G>Cā(p.Val84Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,613,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_016509.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLEC1B | NM_016509.4 | c.250G>C | p.Val84Leu | missense_variant | 3/6 | ENST00000298527.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLEC1B | ENST00000298527.11 | c.250G>C | p.Val84Leu | missense_variant | 3/6 | 1 | NM_016509.4 | P1 | |
CLEC1B | ENST00000348658.4 | c.151G>C | p.Val51Leu | missense_variant | 2/5 | 1 | |||
CLEC1B | ENST00000428126.6 | c.151G>C | p.Val51Leu | missense_variant | 4/7 | 1 | |||
CLEC1B | ENST00000398937.6 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249458Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 135350
GnomAD4 exome AF: 0.000146 AC: 213AN: 1461712Hom.: 0 Cov.: 34 AF XY: 0.000144 AC XY: 105AN XY: 727150
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74312
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at